EGFR/KRAS- germline mutation analyses in advanced non-small cell lung cancer (NSCLC) patients treated with gefitinib/erlotinib
Abstract
Publication Date:
2008
Citation:
EGFR/KRAS- germline mutation analyses in advanced non-small cell lung cancer (NSCLC) patients treated with gefitinib/erlotinib / T. C., G. E., V. E., T. D., G.R. M. I., N. S., D.T. M., P. G. J., A. Falcone, R. Danesi - In: Proceedings 33rd ESMO Congress[s.l], 2008. (( convegno 33rd ESMO Congress tenutosi a Stockholm, Sweden nel 12 - 16 September.
IRIS type:
03 - Contributo in volume
List of contributors:
T. C., G. E., V. E., T. D., G.R. M. I., N. S., D.T. M., P. G. J., A. Falcone, R. Danesi
Link to information sheet:
Book title:
Proceedings 33rd ESMO Congress